End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
994 KRW | +8.52% | -.--% | -80.70% |
03-29 | CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index | CI |
01-24 | Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis | MT |
Performance
1 day | +8.52% | ||
3 months | -33.73% | ||
6 months | -81.07% | ||
Current year | -80.70% | ||
1 year | -91.94% | ||
3 years | -24.51% | ||
5 years | -25.45% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Animal Feed
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+8.52% | -.--% | -80.70% | -91.94% | 137M | ||
+2.60% | +4.39% | +15.92% | +0.99% | 11.94B | ||
+0.53% | +5.38% | +0.86% | -26.04% | 5.88B | ||
0.00% | +9.05% | +5.47% | +13.25% | 5.41B | ||
+1.49% | +0.99% | +4.59% | +0.99% | 4.59B | ||
-0.42% | +2.13% | -19.63% | -31.28% | 2.73B | ||
+1.06% | +2.15% | +3.25% | +0.18% | 1.92B | ||
+1.15% | +6.21% | -17.87% | -14.80% | 1.21B | ||
-1.64% | +3.09% | -18.21% | -12.69% | 948M | ||
-0.26% | +5.57% | -11.45% | -24.73% | 943M | ||
-0.78% | -1.33% | +3.02% | -1.11% | 847M | ||
+0.98% | -4.08% | +23.58% | +41.26% | 846M | ||
+1.73% | +17.87% | +19.95% | +3.63% | 586M | ||
-0.87% | +3.41% | -19.18% | -9.90% | 507M | ||
+0.46% | -3.12% | -21.09% | +3.33% | 453M | ||
+2.06% | -4.95% | -43.00% | -64.07% | 417M | ||
Average | +1.04% | +1.50% | -9.66% | -13.31% | ||
Weighted average by Cap. | +1.13% | +3.76% | +3.43% | -5.33% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -80.70% | ||
2023 | +24.60% | ||
2022 | +285.09% | ||
2021 | +22.43% | ||
2020 | +4.78% | ||
2019 | -37.41% | ||
2018 | +16.91% |
- Stock Market
- Equities
- A016790 Stock
- Quotes CANARIABIO Inc.